Ventas, Inc. (VTR) AI Stock Analysis

Ventas, an S&P 500 company, operates at the intersection of healthcare and real estate, leveraging capital to unlock real estate value. As a Real Estate Investment Trust (REIT), Ventas partners with care providers, developers, research and medical institutions, innovators, and healthcare organizations. The company focuses on demographic tailwinds from an aging population to meet healthcare facility demand. Ventas maintains a diversified portfolio of properties and capital sources to navigate cycles, relying on experienced teams to generate cash flows. As of September 30, 2020, Ventas owned or managed approximately 1,200 properties through unconsolidated joint ventures.

Ventas expanded annual revenue from $3.83B in FY2021 to $4.13B in FY2022, $4.50B in FY2023, $4.92B in FY2024, and $5.83B in FY2025, reflecting a 5-year revenue CAGR of 9.0%. Annual revenue growth reached 18.5% in FY2025, up from 9.5% in FY2024. Operating margin stood at 11.0% in FY2021, 11.7% in FY2022, 9.2% in FY2023, 13.8% in FY2024, and 14.2% in FY2025. After net losses of -$47.4M in FY2022 and -$41.0M in FY2023, net income rose to $81.2M in FY2024 and $251.4M in FY2025. For the latest quarter ended June 30, 2026, quarterly revenue growth was 21.7% year-over-year, while quarterly earnings growth declined 6.7%.

As of June 30, 2026, Ventas held $199.0M in cash and short-term investments against total debt of $13.65B, resulting in net debt of $13.45B. Shareholders' equity stood at $14.65B, resulting in a debt-to-equity ratio of 0.93 and a current ratio of 0.27. During FY2025, operating cash flow reached $1.68B and free cash flow was $1.32B. Cash outlays included capital expenditures of $363.9M and dividends paid of $860.1M, supported by share issuance of $2.45B, contributing to a 5-year share count change of 22.1%.

Ventas carries a market capitalization of $44.04B and trades at a trailing P/E of 159.0x and a forward P/E of 128.2x, compared to the median of its S&P 500 Real Estate peers of 30.3x and 29.2x, respectively. Its EV to EBITDA ratio of 23.9x is higher than the peer group median of 17.2x, while its price-to-sales multiple of 6.9x compares to the peer median of 7.1x. Over the past year, Ventas returned 26.5%, surpassing the 16.8% return for SPY, while its 5-year return of 81.0% trailed the 83.0% return of SPY.

Ventas provides an annual forward dividend of $2.08, yielding 2.42% with a payout ratio of 1.6%. The company pays dividends quarterly and has paid dividends for 28 consecutive years. Its 5-year annualized dividend growth stands at -2.2%, and its last ex-dividend date occurred on September 30, 2026.

Wall Street coverage consists of 14 Strong Buy, 4 Buy, and 5 Hold recommendations, with zero Sell ratings. The mean price target of $100.86 represents an upside of 17.5% from the last close of $85.86. Ventas beat EPS estimates in 3 of the last 4 quarters. For the current fiscal year ending December 31, 2026, analysts estimate revenue of $6.97B and EPS of $0.44. The next earnings date is October 27, 2026.

This page is an AI-written research summary of Ventas, Inc. (VTR). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: VTR income statement, VTR balance sheet, VTR key metrics, VTR analyst forecast, VTR chart. See the VTR stock overview for the latest quote and news.